Binghe Xu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-0234-2747

发表论文 260 篇 · 总被引 5995 次 · h-index 33

代表论文

• The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study (2025 · The Breast · 被引 9)
• Sustainable resource utilization of industrial by-product gypsum: Low-energy rapid joule heating for calcium sulfide production (2025 · Chemical Engineering Journal · 被引 5)
• Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in NATALEE: Analysis across menopausal status and age. (2025 · Journal of Clinical Oncology · 被引 4)
• CBERTaXGB: A domain-specific transformer-XGBoost hybrid for chemical toxicity and flammability prediction (2025 · Process Safety and Environmental Protection · 被引 3)
• Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer (2025 · Cancer Cell International · 被引 3)
• Abstract PS2-05: PRESERVE 2: A randomized, phase 3, double-blind trial of trilaciclib or placebo in patients (pts) receiving first-line gemcitabine/carboplatin (GCb) for locally advanced or metastatic triple-negative breast cancer (mTNBC) (2025 · Clinical Cancer Research · 被引 2)